IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Date	Title
18/08/2008	Tysabri (natalizumab)-Important Safety Information from Elan/Biogen Idec as approved by the IMB
01/08/2008	Application for a Registration Certificate for a Homeopathic Veterinary Medicinal Product
01/08/2008	Thalidomide Pharmion-Important Safety Information from Celgene as approved by the IMB
28/07/2008	Dostinex (cabergoline)-Important Safety Information from Pfizer as approved by the IMB
28/07/2008	Cabaser (cabergoline)-Important Safety Information from Pfizer as approved by the IMB
21/07/2008	Celance (pergolide)-Important Safety Information from Lilly as approved by the IMB
16/07/2008	Humira (adalimumab)-Important Safety Information from Abbott Laboratories as approved by the IMB
14/07/2008	Acomplia (rimonabant)-Important Safety Information from Sanofi Aventis as approved by the IMB
10/07/2008	Exjade (deferasirox)-Important Safety Information from Novartis as approved by the IMB
10/07/2008	Avastin (bevacizumab) & sunitinib malate-Important Safety Information from Roche as approved by the IMB
08/07/2008	Revlimid (lenalidomide)-Important Safety Information from Celgene as approved by the IMB
03/07/2008	IMB Newsletter Issue No 29 January - April 2008
03/07/2008	HMA-Vet PSUR work-sharing initiative
18/06/2008	Reporting Serious Adverse Reactions (SARs) and Serious Adverse Events (SAEs) associated with Human Tissues
11/06/2008	Guide to the Registration of Homeopathic Medicinal Products
11/06/2008	Neupro (rotigotine)-Important Information from UCB (Pharma) on the recall of certain packs
03/06/2008	Guide to Drug-Device Consultations
03/06/2008	Application for a Drug-Device Consultation
26/05/2008	Tysabri (natalizumab)-Important Safety Information from Elan/Biogen Idec concerning serious hepatic reactions with Tysabri
21/05/2008	Drug Safety Newsletter 27th Edition